| Septic shock D Annane, E Bellissant, JM Cavaillon The Lancet 365 (9453), 63-78, 2005 | 2003 | 2005 |
| Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome C Adrie, M Adib-Conquy, I Laurent, M Monchi, C Vinsonneau, C Fitting, ... Circulation 106 (5), 562-568, 2002 | 1284 | 2002 |
| Dysregulation of in vitro cytokine production by monocytes during sepsis. C Munoz, J Carlet, C Fitting, B Misset, JP Blériot, JM Cavaillon The Journal of clinical investigation 88 (5), 1747-1754, 1991 | 966 | 1991 |
| Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis JM Cavaillon, M Adib-Conquy Critical care 10, 1-8, 2006 | 618 | 2006 |
| Compensatory anti-inflammatory response syndrome M Adib-Conquy, JM Cavaillon Thrombosis and haemostasis 101 (01), 36-47, 2009 | 602 | 2009 |
| Cytokines and macrophages JM Cavaillon Biomedicine & pharmacotherapy 48 (10), 445-453, 1994 | 570 | 1994 |
| The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, ... The Lancet Respiratory Medicine 9 (6), 622-642, 2021 | 528 | 2021 |
| Cytokine cascade in sepsis J Cavaillon, M Adib-Conquy, C Fitting, C Adrie, D Payen Scandinavian journal of infectious diseases 35 (9), 535-544, 2003 | 521 | 2003 |
| Comparative study of injury models for studying muscle regeneration in mice D Hardy, A Besnard, M Latil, G Jouvion, D Briand, C Thépenier, Q Pascal, ... PloS one 11 (1), e0147198, 2016 | 501 | 2016 |
| Pro-versus anti-inflammatory cytokines: myth or reality JM Cavaillon Cellular And Molecular Biology-Paris-Wegmann- 47 (4), 695-702, 2001 | 495 | 2001 |
| Synergistic stimulation of human monocytes and dendritic cells by Toll‐like receptor 4 and NOD1‐and NOD2‐activating agonists JH Fritz, SE Girardin, C Fitting, C Werts, D Mengin‐Lecreulx, M Caroff, ... European journal of immunology 35 (8), 2459-2470, 2005 | 470 | 2005 |
| Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial D Payen, J Mateo, JM Cavaillon, F Fraisse, C Floriot, E Vicaut Critical care medicine 37 (3), 803-810, 2009 | 380 | 2009 |
| Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? MG Netea, M van Deuren, BJ Kullberg, JM Cavaillon, JWM Van der Meer Trends in immunology 23 (3), 135-139, 2002 | 373 | 2002 |
| Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. OJ Perdomo, JM Cavaillon, M Huerre, H Ohayon, P Gounon, ... The Journal of experimental medicine 180 (4), 1307-1319, 1994 | 340 | 1994 |
| Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS JM Cavaillon, D Annane Journal of endotoxin research 12 (3), 151-170, 2006 | 339 | 2006 |
| Exotoxins and endotoxins: Inducers of inflammatory cytokines JM Cavaillon Toxicon 149, 45-53, 2018 | 338 | 2018 |
| Structural and functional analyses of bacterial lipopolysaccharides M Caroff, D Karibian, JM Cavaillon, N Haeffner-Cavaillon Microbes and infection 4 (9), 915-926, 2002 | 313 | 2002 |
| Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin C Marty, B Misset, F Tamion, C Fitting, J Carlet, JM Cavaillon Critical care medicine 22 (4), 673-679, 1994 | 313 | 1994 |
| Current gaps in sepsis immunology: new opportunities for translational research I Rubio, MF Osuchowski, M Shankar-Hari, T Skirecki, MS Winkler, ... The Lancet infectious diseases 19 (12), e422-e436, 2019 | 309 | 2019 |
| Resilience to bacterial infection: difference between species could be due to proteins in serum HS Warren, C Fitting, E Hoff, M Adib-Conquy, L Beasley-Topliffe, B Tesini, ... The Journal of infectious diseases 201 (2), 223-232, 2010 | 302 | 2010 |
